BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 10, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

EES gastric band, web tool may offer greater weight loss

June 24, 2010
By Omar Ford

FDA to accept PMA filing for ev3's embolization device

June 23, 2010
By Omar Ford

Dual assay approach used to detect HIV in patients faster

June 22, 2010
By Omar Ford

Medtronic's catheters reduce lab time required for PVI by 35%

June 21, 2010
By Omar Ford
Medtronic's (Minneapolis) latest supported study is more of a tale of two devices and how both could dramatically improve traditional pulmonary vein isolation (PVI). (Medical Device Daily)
Read More

Study: regulation, growing global market concerns for device makers

June 18, 2010
By Omar Ford
Healthcare reform and the globalization of the healthcare industry are the two topics that are constantly on healthcare executives minds, according to a research study conducted by Harris Interactive (Rochester, New York) for United Parcel Service (UPS; Atlanta). The agency, which transports a great deal of medical devices and applications from vendors to companies released the results of its third annual UPS "Pain in the (Supply) Chain survey of senior-level healthcare executives. The survey was designed to help identify the greatest pain points and future trends in the supply chains of med-tech companies. (Medical Device Daily)
Read More

Pathwork gains approval for its new Tissue of Origin test

June 16, 2010
By Omar Ford

Lantheus' LMI provides clear, safe cardiovascular images

June 15, 2010
By Omar Ford
Lantheus Medical (North Billerica, Massachusetts) reported that it has released phase 1 data for its heart failure PET imaging agent, LMI 1195, which is in development for the evaluation of patients at risk of heart failure or sudden cardiac death. (Medical Device Daily)
Read More

Checkpoint's neurostimulation device launched nationwide

June 14, 2010
By Omar Ford

Ekos wins $2.7M NIH grant for ICH treatment device

June 10, 2010
By Omar Ford

BD offers up nano-sized needle to deliver insulin

June 9, 2010
By Omar Ford
Previous 1 2 … 174 175 176 177 178 179 180 181 182 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Art concept for inflammation in the intestines

    Kymera’s IRF5 degrader shows potential in IBD treatment

    BioWorld Science
    At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing